"Collaborate to catalyse Research" Venezia Lido (Italy) - European ...

76 9 th EAPC Congress 2005
European Association for
Palliative Care
We thank our main sponsors Grünenthal, Janssen-Cilag and Mundipharma Napp
and all other sponsors for the great support.
MAIN SPONSORS
Grünenthal is a research-based, independent,
family-owned, pharmaceutical
company, operating internationally and
focussing on pain therapy and gynaecology.
It was founded in Stolberg in 1946.
Core activities are the development of
new analgesic medicines and the improvement
of pain management by quality initiatives
and educational tools. The research
and development pipeline contains new
chemical entities and advanced pharmaceutical
delivery technologies.
Grünenthal GmbH is the originator of
the centrally acting analgesic tramadol
(Tramal ® ). With Transtec ® it has introduced
an innovative buprenorphine patch
in most European countries.
For many years Grünenthal GmbH has
been endeavouring to improve palliative
care in Europe, and the first chair of palliative
medicine in Germany was set up
by the Grünenthal Foundation at Aachen
University in 1998. Further foundations
have followed in Spain and Portugal.
Grünenthal GmbH is currently represented
in 23 countries with affiliates in virtually
all European countries. Grünenthal GmbH
has production sites in six countries. In
2004 Grünenthal GmbH employed about
1,850 people in Germany and 4,700
world-wide.
Grünenthal GmbH
52099 Aachen
Germany
Website: www.grunenthal.com